The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
After being informed about the study and potential risks, all patients giving written informed consent will be asked to complete a small questionnaire regarding family history and have a blood sample withdrawn. Blood samples, questionnaires, clinical information and signed consent is send to Department of Medical Genetics, Telemark Hospital Trust were the genetic analysis is performed successively throughout the recruitment period. Patients can choose to have their genetic results returned in a diagnostic setting.
Study Type
OBSERVATIONAL
Enrollment
1,200
Observation of genetic characteristics
Haukeland University Hospital, Department of Neurology
Bergen, Norway
RECRUITINGGene frequency
Number of patients with disease causing mutations in high penetrant ALS genes
Time frame: 2020-2030
New ALS genes
Identify new ALS genes in the Norwegian ALS population
Time frame: 2024-2030
Genetic risk factors
Identify genetic risk factors for ALS in Norway.
Time frame: 2022-2030
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nordland Hospital Trust, Department of Neurology
Bodø, Norway
RECRUITINGVestre Viken Hospital Trust, Department of Neurology
Drammen, Norway
RECRUITINGFørde Hospital Trust, Department of Neurology
Førde, Norway
RECRUITINGØstfold Hospital Trust, Department of Neurology
Grålum, Norway
RECRUITINGFonna Hospital Trust, Department of Neurology
Haugesund, Norway
RECRUITINGSørlandet Hospital Trust, Department of Neurology
Kristiansand, Norway
RECRUITINGInnlandet Hospital Trust, Department of Neurology
Lillehammer, Norway
RECRUITINGAkershus University Hospital, Department of Neurology
Lørenskog, Norway
RECRUITINGMøre and Romsdal Hospital Trust, Department of Neurology
Molde, Norway
RECRUITING...and 7 more locations